Journals / Nefroloji Hemşireliği Dergisi / 2021 / Cilt: 16 - Sayı: 2

Covid-19 of Pandemic and Impact on Patients with Chronic Kidney Disease

Covid-19 Pandemisi ve Kronik Böbrek Hastalarına Etkisi / Covid-19 of Pandemic and Impact on Patients with Chronic Kidney Disease

Pages
60–66
Publication Date
2021-05-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, it has been discussed how Covid-19 infection affects the function of the kidney and patients treated for chronic kidney disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:“Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV2)”, a single-stranded, positive polarity, weak RNA virus, has spread all over the world in a short time.
📊
Key Findings & Data:The incubation period of the SARS-CoV-2 virus, which is the causative agent of Covid-19, is between 2-14 days according to the available data and it commonly presents with symptoms such as weakness, fever, sore throat, dry cough, shortness of breath, joint pain, loss of smell.
💡
Conclusion & Impact:In this article, it has been discussed how Covid-19 infection affects the function of the kidney and patients treated for chronic kidney disease.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Covid-19 · Hemodiyaliz · Periton diyalizi

Abstract

“Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV2)”, a single-stranded, positive polarity, weak RNA virus, has spread all over the world in a short time. The incubation period of the SARS-CoV-2 virus, which is the causative agent of Covid-19, is between 2-14 days according to the available data and it commonly presents with symptoms such as weakness, fever, sore throat, dry cough, shortness of breath, joint pain, loss of smell. The fact that Covid-19 infection mostly causes acute kidney injury in patients and the presence of more than one comorbid disease in most chronic kidney patients causes an increase in mortality and morbidity rates in chronic kidney patients. When kidney functions were examined in patients hospitalized with the diagnosis of Covid-19, 59% of the patients had proteinuria, 44% had hematuria, 31% had blood urea nitrogen (BUN) and 22% had increased serum creatinine levels and signs of kidney dysfunction. Patients undergoing hemodialysis, peritoneal dialysis, and kidney transplantation, whose immune systems are suppressed due to uremia, are indicated as a high-risk group for Covid-19 infection. In this article, it has been discussed how Covid-19 infection affects the function of the kidney and patients treated for chronic kidney disease.

Özet

Tek zincirli, pozitif polariteli, zayıf bir RNA virüsü olan “SevereAcute Respiratory Syndrome Coronavirüs-2 (SARS-CoV2)”kısa sürede tüm dünyaya yayılmıştır. Covid-19 etkeni olanSARS-CoV-2 virüsünün kuluçka süresinin mevcut verilere göre2-14 gün arasında olduğu ve yaygın olarak halsizlik, ateş, boğazağrısı, kuru öksürük, nefes darlığı, eklem ağrısı, koku kaybı gibisemptomlar ile belirti vermektedir. Covid-19 enfeksiyonunun,hastalarda çoğunlukla akut böbrek hasarına yol açması ve kronikböbrek hastalarının çoğunda birden fazla komorbid hastalıkvarlığının mevcut olması kronik böbrek hastalarında mortaliteve morbidite oranlarının artmasına neden olmaktadır. Covid-19tanısıyla hastaneye yatan hastalarda böbrek fonksiyonlarıincelendiğinde, hastaların %59'u proteinüri, %44'ü hematüribulunduğu, %31'inin kan üre nitrojenin (BUN) ve %22'sininserum kreatinin düzeyinin arttığı ve böbrek fonksiyonbozukluğu belirtileri bulunduğu görülmüştür. Üremi nedeniylebağışıklık sistemleri baskılanmış olan hemodiyaliz, peritondiyaliz ve böbrek transplantasyonu yapılan hastalar, Covid-19enfeksiyonu için yüksek riskli grup olarak belirtilmektedir. Buderlemede, Covid-19 enfeksiyonunun böbrek fonksiyonlarını vekronik böbrek hastalığı tedavisi gören hastaları nasıl etkilediğineyer verilmiştir.

🔖

Cite This Article

ÖZDEMİR, S. T. (2021). Covid-19 of Pandemic and Impact on Patients with Chronic Kidney Disease. Nefroloji Hemşireliği Dergisi, Cilt: 16 - Sayı: 2, 60–66. https://ajindex.com/articles/195814

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Ünsal Avdal E. Covid-19: Komorbid durumlarda bakım yönetimi. Şenuzun Aykar F, editör. İç Hastalıkları Hemşireliği ve Covid-19
  2. Baskı. Ankara: Türkiye Klinikleri 2020:10-14
  3. Bayrakçı N, Özkan G. Covid-19 pandemisinde nefroloji kliniklerinin yönetimi. Namık Kemal Tıp Dergisi 2020; 8(3): 355-363
  4. Dede Ş, Kayabaşı H. Sars-COV-2 ile ilişkili akut böbrek hasarı. Dicle Tıp Dergisi 2020;47(2): 498-507
  5. WHO Coronavirus Disease (COVID-19) Dashboard. https://covid19.who.int Erişim tarihi: 20.05.2021
  6. T.C. Sağlık Bakanlığı, Covıd-19 Bilgilendirme Sayfası. https://covid19.saglik.gov.tr/ Erişim tarihi: 20.05.2021 6. Benedetti C, Waldman M, Zaza G, Riella L, Cravedi P. Covid-19 and the kidneys: an update. Frontiers in Medicine 2020;7:423
  7. Çelik D, Köse Ş. Erişkinlerde Covid-19: Klinik bulgular. Tepecik Eğitim ve Araştırma Hastanesi Dergisi 2020;30(Ek sayı):43-8
  8. Noordzij M, Duivenvoorden R, Pena M.J, de Vries H, Kieneker L M. fort he collaborative ERACODA authors. ERACODA: the European database collecting clinical information of patients on kidney replacement therapy with COVID-19. Nephrology, Dialysis, Transplantation 2020;35: 2023–2025. 9. https://www.epicentro.iss.it/en/coronavirus/bollettino/Report-COVID-2019_16_december_2020.pdf (Erişim tarihi: 20.12.2020)
  9. Li Z, Wu M, Yao J, Guo J, Liao X. et al. Caution on kidney dysfunctions of Covid-19 patients. medRxiv. 2020;51:343–348. doi.org/10.1101/2020.02.08.20021212 11. Topbaş E. Covid-19 sürecinde böbrek yetmezliği olan hastanın yoğun bakım yönetimi. Yoğun Bakım Hemşireliği Dergisi 2020;24(EK-1):61-67
  10. Hardenberg JHB, Luft FC. Covid‐19, ACE2 and the kidney. Acta Physiologica 2020;230:e13539. https://doi.org/10.1111/ apha.13539
  11. Durvasula R, Wellington T, Mcnamara E, Watnick S. Covid-19 and kidney failure in the acute care setting: our experience from seattle. American Journal of Kidney Diseases. 2020;76 (1); 4-6
  12. Gabarre P, Dumas G, Dupont T, Darmon M, Azoulay E. et al. Acute kidney injury in critically ill patients with Covid19. Intensive Care Medicine. 2020;46:1339–1348.
  13. Ronco C, Reis T. Kidney involvement in Covid-19 and rationale for extracorporeal therapies. Nature Reviews Nephrology. 2020;16(6):308-310
  14. Naicker S, Yang CW, Hwang SJ, Liu BC, Chen JH. et al. The Novel Coronavirus 2019 epidemic and kidneys. Kidney International. 2020;97(5):824-828
  15. Wang L, Li X, Chen H, Yan S, Li D. et al. Coronavirus disease 19 infection d